2006
DOI: 10.1167/iovs.05-1612
|View full text |Cite
|
Sign up to set email alerts
|

Contrasting Blue-on-Yellow with White-on-White Visual Fields: Roles of Visual Adaptation for Healthy Peri- or Postmenopausal Women Younger Than 70 Years of Age

Abstract: Much of the extra variability in SWAP sensitivities for a select group of healthy women can be accounted for by differences in the degree of desensitization induced by the yellow background used for SWAP. For clinical practice, pupil status (dilated or undilated) should be altered only with caution from one SWAP testing session to another.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 43 publications
0
12
0
Order By: Relevance
“…That is, tamoxifen users as a group were more likely than non-BC control subjects to perceive a short-wavelength incremental test stimulus on a yellow adapting background as “white” rather than as colored. Moreover, long-term users were significantly more likely than short-term users to perceive this stimulus as “white” despite not having a selective reduction of SWS-cone-mediated sensitivity at the fovea,184 The absence of a foveal sensitivity loss implied that the perception of white did not result from an acquired tritanopic defect, as might otherwise have been assumed, and estimates of lens density obtained psychophysically183 were unrelated to the choice of color name (unpublished results). Instead, the perception of white more likely resulted from an acquired temporal-response sluggishness that caused the color from the short-wavelength test stimulus to combine, rather than to contrast, with the color from the yellow background stimulus 182.…”
Section: Adjuvant Endocrine Therapymentioning
confidence: 92%
“…That is, tamoxifen users as a group were more likely than non-BC control subjects to perceive a short-wavelength incremental test stimulus on a yellow adapting background as “white” rather than as colored. Moreover, long-term users were significantly more likely than short-term users to perceive this stimulus as “white” despite not having a selective reduction of SWS-cone-mediated sensitivity at the fovea,184 The absence of a foveal sensitivity loss implied that the perception of white did not result from an acquired tritanopic defect, as might otherwise have been assumed, and estimates of lens density obtained psychophysically183 were unrelated to the choice of color name (unpublished results). Instead, the perception of white more likely resulted from an acquired temporal-response sluggishness that caused the color from the short-wavelength test stimulus to combine, rather than to contrast, with the color from the yellow background stimulus 182.…”
Section: Adjuvant Endocrine Therapymentioning
confidence: 92%
“…Subjects for this study met the same eligibility criteria as did the subjects for an earlier visual field study (Eisner et al 2006b) that used a four-factor multivariate linear regression model (three visual function factors plus a pupil size factor) to account for SWAP -W ⁄ W differences in the periphery of the visual field for healthy women. In fact, the subjects for the present study included all 26 subjects for that previous study plus additional subjects recruited later.…”
Section: Subjectsmentioning
confidence: 99%
“…(Eisner et al 2006b)]. Subjects were volunteers who served as control subjects for several studies concerning effects of breast cancer medications on the eye (Eisner et al 2006a(Eisner et al , 2007(Eisner et al , 2009) and vision (Eisner & Incognito 2006;, but whose data were also analysed in their own right (Eisner et al 2006b;. None of the subjects for any studies was paid, as many women are highly motivated to contribute to breast cancer research and we wished to eliminate any monetary motivation.…”
Section: Subjectsmentioning
confidence: 99%
See 1 more Smart Citation
“…All subjects met a rigorous set of eligibility criteria concerning ocular health, described previously [1619]. The most salient criteria are: (i) best-corrected visual acuity of 20/20 or better in one eye and 20/25 or better in the other, (ii) no evidence or suspicion of eye disease, (iii) no diabetes, (iv) no myopia > 5 diopters, (v) no use of medication (other than anastrozole [17] or tamoxifen [2022]) known to affect vision, and (vi) no ocular surgery.…”
Section: Methodsmentioning
confidence: 99%